semaglutide alcohol use disorder study I'm grateful to be quoted in Forbes discussing a new Lancet looking at and in people with obesity. The study found that adults with alcohol use disorder RCT: Semaglutide reduces alcohol craving

Third, GLP1s influence on gut microbiota and the gutbrain axis may also play a role, given the emerging evidence tying gut health to mental health

and a shareholder in Novo Nordisk

In clinical trials, GLP-1 therapies have been shown to 14: Reduce HbA1C (a snapshot of blood sugar over three months) Support weight loss Improve overall metabolic control They are often used when first-line treatments like metformin are not enough, or when weight loss and cardiometabolic risk are key considerations

One in sixteen is actively taking one as of 2024

Conversely, diets high in refined carbohydrates, saturated fats, and added sugars can exacerbate hepatic fat accumulation

Do not stop taking this medication without consulting your healthcare provider because some conditions may become worse when the drug is suddenly stopped